Vasohibin 2 Decreases the Cisplatin Sensitivity of Hepatocarcinoma Cell Line by Downregulating p53

Hepatocellular carcinoma (HCC) is a prevalent problem worldwide. Chemotherapy, especially cisplatin (CDDP)-based systemic chemotherapy, is the best option for advanced liver cancer. However, CDDP resistance is becoming common and hindering the clinical application of CDDP. Meanwhile, no consensus ha...

Full description

Saved in:

Bibliographic Details
Main Authors:	Li, Zhanjun, Tu, Min, Han, Bei, Gu, Yuqing, Xue, Xiaofeng, Sun, Jie, Ge, Qianqian, Miao, Yi, Qian, Zhuyin, Gao, Wentao
Format:	Artigo
Language:	Inglês
Published:	Public Library of Science 2014
Subjects:	Research Article
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3942424/ https://ncbi.nlm.nih.gov/pubmed/24595063 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0090358
Tags:	Add Tag No Tags, Be the first to tag this record!

Vasohibin 2 Decreases the Cisplatin Sensitivity of Hepatocarcinoma Cell Line by Downregulating p53

Similar Items